In the case of leukemia, Niu et al. [109] also showed that knockdown of BCR-ABL in chronic myeloid leukemia (CML) cells downregulated plakoglobin expression and suppressed β-catenin by activating GSK-3β [109]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.